Article
Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).
International journal of cancer - 15 Mar 2012
Ter-Minassian Monica, Asomaning Kofi, Zhao Yang, Chen Feng, Su Li, Carmella Steven G, Lin Xihong, Hecht Stephen S, Christiani David C
Abstract excerpt
Urinary metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides, termed total NNAL, have recently been shown to be good predictors of lung cancer risk, years before diagnosis. We sought to determine the contribution of several genetic polymorphisms to total NNAL output and inter-individual...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
